These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 14566839)
1. Identification of a sperm protein 17 CTL epitope restricted by HLA-A1. Chiriva-Internati M; Wang Z; Pochopien S; Salati E; Lim SH Int J Cancer; 2003 Dec; 107(5):863-5. PubMed ID: 14566839 [TBL] [Abstract][Full Text] [Related]
2. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumour-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma. Chiriva-Internati M; Wang Z; Salati E; Wroblewski D; Lim SH Scand J Immunol; 2002 Oct; 56(4):429-33. PubMed ID: 12234264 [TBL] [Abstract][Full Text] [Related]
3. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734 [TBL] [Abstract][Full Text] [Related]
4. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk. Chiriva-Internati M; Wang Z; Xue Y; Bumm K; Hahn AB; Lim SH Eur J Immunol; 2001 Aug; 31(8):2277-83. PubMed ID: 11477539 [TBL] [Abstract][Full Text] [Related]
5. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. Kittlesen DJ; Thompson LW; Gulden PH; Skipper JC; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH; Slingluff CL J Immunol; 1998 Mar; 160(5):2099-106. PubMed ID: 9498746 [TBL] [Abstract][Full Text] [Related]
6. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010 [TBL] [Abstract][Full Text] [Related]
7. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme. Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247 [TBL] [Abstract][Full Text] [Related]
8. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen. Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571 [TBL] [Abstract][Full Text] [Related]
9. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2. Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519 [TBL] [Abstract][Full Text] [Related]
10. Tumor vaccine for ovarian carcinoma targeting sperm protein 17. Chiriva-Internati M; Wang Z; Salati E; Timmins P; Lim SH Cancer; 2002 May; 94(9):2447-53. PubMed ID: 12015770 [TBL] [Abstract][Full Text] [Related]
11. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma. Chiriva-Internati M; Wang Z; Salati E; Bumm K; Barlogie B; Lim SH Blood; 2002 Aug; 100(3):961-5. PubMed ID: 12130509 [TBL] [Abstract][Full Text] [Related]
12. Identification of an epitope from the epithelial cell adhesion molecule eliciting HLA-A*2402-restricted cytotoxic T-lymphocyte responses. Tajima K; Demachi A; Ito Y; Nishida K; Akatsuka Y; Tsujimura K; Kuwano H; Mitsudomi T; Takahashi T; Kuzushima K Tissue Antigens; 2004 Dec; 64(6):650-9. PubMed ID: 15546337 [TBL] [Abstract][Full Text] [Related]
13. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes. Sarkar AK; Nuchtern JG Cancer Res; 2000 Apr; 60(7):1908-13. PubMed ID: 10766179 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain. Okano F; Storkus WJ; Chambers WH; Pollack IF; Okada H Clin Cancer Res; 2002 Sep; 8(9):2851-5. PubMed ID: 12231526 [TBL] [Abstract][Full Text] [Related]
15. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423 [TBL] [Abstract][Full Text] [Related]
16. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele. Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698 [TBL] [Abstract][Full Text] [Related]
17. Identification of a potential human telomerase reverse transcriptase-derived, HLA-A1-restricted cytotoxic T-lymphocyte epitope. Schreurs MW; Kueter EW; Scholten KB; Kramer D; Meijer CJ; Hooijberg E Cancer Immunol Immunother; 2005 Jul; 54(7):703-12. PubMed ID: 15726360 [TBL] [Abstract][Full Text] [Related]
18. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2. Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494 [TBL] [Abstract][Full Text] [Related]
19. Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells. Liu Y; Tian X; Jiang S; Ren X; Liu F; Yang J; Chen Y; Jiang Y Cell Immunol; 2015; 298(1-2):18-24. PubMed ID: 26300426 [TBL] [Abstract][Full Text] [Related]
20. Identification of T cell epitopes by the use of rapidly generated mRNA fragments. Britten CM; Meyer RG; Graf C; Huber C; Wölfel T J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]